​Regeneron’s Antibody COVID Treatment Uses an Aborted Fetal Cell Line

Even though Regeneron’s experimental COVID-19 drug, REGN-COV2, got its start with cells derived from a human fetal cell line, the company says it doesn’t consider the treatment as one relying on fetal tissue. The HEK293T “immortalized” cell lines were acquired from an aborted fetus so long ago — the 1970s — and have been divided and grown in cultures so many times that they’re simply considered “a tool” for research, the company told ABC...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports